Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors

Factor replacement therapy for the treatment of moderate to severe haemophilia A and B can be complicated by the production of inhibitory alloantibodies to factor VIII (FVIII) or factor IX. Treatment with the nanofiltered anti-inhibitor coagulant complex, Factor Eight Inhibitor Bypassing Activity (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, S V, Tangada, S, Stasyshyn, O, Mamonov, V, Phillips, J, Guzman-Becerra, N, Grigorian, A, Ewenstein, B, Wong, W-Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216433/
https://www.ncbi.nlm.nih.gov/pubmed/23910578
http://dx.doi.org/10.1111/hae.12246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216433/
https://www.ncbi.nlm.nih.gov/pubmed/23910578
http://dx.doi.org/10.1111/hae.12246

Ejemplares similares